Levocabastine is a potent, selective histamine H1-receptor antagonist used primarily for the symptomatic treatment of allergic rhinitis and allergic conjunctivitis. It reduces histamine-mediated allergic responses such as itching, redness, sneezing and watery discharge.
Levocabastine is commonly formulated for topical nasal and ophthalmic administration, providing local antihistamine activity at the site of allergic symptoms.
Levocabastine is a specialized antihistamine pharmaceutical API manufactured through controlled chemical synthesis, purification and crystallization.
Important quality attributes include identity, assay, related substances, stereochemical purity, water content, residual solvents, elemental impurities and stability.
CAS Number: 79547-78-1
Molecular Formula: C26H29FN2O2
Molecular Weight: 404.52 g/mol
Drug Class: Antihistamine
Pharmacological Class: H1-Receptor Antagonist
Therapeutic Class: Antiallergic Agent
Therapeutic Area: Allergy / Ophthalmology / Respiratory
Levocabastine selectively antagonizes histamine H1 receptors.
During an allergic reaction, histamine contributes to symptoms such as vasodilation, increased vascular permeability, itching and smooth-muscle stimulation. By blocking H1 receptors, levocabastine helps reduce these effects.
It can therefore reduce:
Levocabastine is used primarily in topical formulations for:
Levocabastine is a highly selective H1 antagonist designed for local treatment of allergic symptoms. Its topical administration allows the active ingredient to act directly at nasal or ocular tissues.
Typical API manufacturing may involve:
Levocabastine API quality evaluation may include:
Levocabastine should be stored in a tightly closed container under controlled pharmaceutical storage conditions, protected from excessive heat, moisture and direct light. Final storage requirements should be established through validated stability studies.
Levocabastine is relevant to research involving:
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Individual Impurity | ≤ 0.5% |
| Total Impurities | ≤ 1.5% |
| Water Content | NMT 1.0% |